by angelliu | Aug 3, 2018 | News
Source: FiercePharma Allergan, which is shopping assets to help turn its stock price around, has taken its first small step into selloff land. Spain’s Almirall said Friday it had agreed to pick up a portfolio of medical dermatology products from the Dublin drugmaker...
by angelliu | Jul 31, 2018 | News
Source: Reuters FRANKFURT (Reuters) – Bayer has agreed to sell its established prescription dermatology brands to Denmark’s Leo Pharma, as the German drugmaker focuses on integrating seed maker Monsanto and on bolstering its drug development pipeline. The...
by angelliu | Jul 24, 2018 | News
Source: Sienna Biopharmaceuticals Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA), a clinical-stage medical dermatology and aesthetics company, today announced results from a Phase 1b maximal use (MUse) pharmacokinetic (PK) and safety study of SNA-120 (pegcantratinib),...
by angelliu | Jul 10, 2018 | News
Source: Cassiopea Lainate, Italy – 10 July 2018 – Cassiopea SpA (SIX: SKIN), a clinical-stage specialty pharmaceutical company focused on developing and commercializing innovative and differentiated medical dermatology products, today announced that top line...
by angelliu | Jun 19, 2018 | Testimonials
“Working with Rick has been a pleasure. He truly looks at how to best put a person in a place to be successful and land a position which is one or two levels up from where they are currently at based on their skill sets. He continuously searches for...
